Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | +3.63% | +12.36% | -86.41% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.41% | 136M | |
-3.79% | 87.06B | |
+2.76% | 40.25B | |
-17.49% | 31.09B | |
+54.56% | 24.74B | |
-13.13% | 15.91B | |
-9.12% | 11.96B | |
-15.45% | 11.92B | |
-42.56% | 11.61B | |
+5.09% | 8.73B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Sector Update: Health Care Stocks Steady Pre-Bell Friday